From: Investment case for improving maternal and child health: results from four countries
Key causes of death | Impact (% Reduction over 5 years) | Cost ($US) | |||||
---|---|---|---|---|---|---|---|
Maternal | Under-5 | Maternal mortality ratio | Neonatal mortality rate | Under-5 mortality rate | Annual marginal recurrent cost (per capita) | First year capital cost (per capita) | |
Kendrapara | Post-partum Haemorrhage (28%), Sepsis/Infections (11%), Unsafe Abortion (10%), Ante-partum Haemorrhage (9%)* | Preterm birth (17%), Diarrhoea (16%), Pneumonia (16%), Neonatal Sepsis (15%), Birth Asphyxia (13%)‡ | 34% (30%-38%) | 35% (33%-38%) | 23% (21%-26%) | $1.61 ($1.61-1.63) | $1.70 |
Key Strategies: renovation and construction of sub-health centres, upgrading of emergency maternal and neonatal care facilities, additional training for staff on postnatal care, performance incentives and travel/hardship allowances for staff, workforce planning, supervision and monitoring, ensuring supply of buffer drug stocks, community promotion activities | |||||||
Rayagada | Anaemia (24%), Post-partum Haemorrhage (17%), Sepsis/Infection (17%), Hypertension (14%) † | Diarrhoea (18%), Pneumonia (17%), Preterm birth (16%), Neonatal Sepsis (14%), Birth Asphyxia (12%)§ | 28% (23%-33%) | 35% (32%-38%) | 25% (22%-27%) | $3.92# | $3.56 |
Key Strategies: as above |